| Literature DB >> 26244334 |
Saioa López1, Isabel Smith-Zubiaga2, Alicia García de Galdeano3, María Dolores Boyano4, Oscar García5, Jesús Gardeazábal6, Conrado Martinez-Cadenas7, Neskuts Izagirre1, Concepción de la Rúa1, Santos Alonso1.
Abstract
We analysed the whole-genome transcriptional profile of 6 cell lines of dark melanocytes (DM) and 6 of light melanocytes (LM) at basal conditions and after ultraviolet-B (UVB) radiation at different time points to investigate the mechanisms by which melanocytes protect human skin from the damaging effects of UVB. Further, we assessed the effect of different keratinocyte-conditioned media (KCM+ and KCM-) on melanocytes. Our results suggest that an interaction between ribosomal proteins and the P53 signaling pathway may occur in response to UVB in both DM and LM. We also observed that DM and LM show differentially expressed genes after irradiation, in particular at the first 6h after UVB. These are mainly associated with inflammatory reactions, cell survival or melanoma. Furthermore, the culture with KCM+ compared with KCM- had a noticeable effect on LM. This effect includes the activation of various signaling pathways such as the mTOR pathway, involved in the regulation of cell metabolism, growth, proliferation and survival. Finally, the comparison of the transcriptional profiles between LM and DM under basal conditions, and the application of natural selection tests in human populations allowed us to support the significant evolutionary role of MIF and ATP6V0B in the pigmentary phenotype.Entities:
Mesh:
Year: 2015 PMID: 26244334 PMCID: PMC4526690 DOI: 10.1371/journal.pone.0134911
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Graphical scheme of the experimental design.
Fig 2Principal Component Analysis.
Charts a) and b) show the same 2-dimesional representation of the data according to the first 2 principal components, but colored according to different variables. Thus, in a) the effects of time (Squares: Time = 0; Dots: Time = 6 hours; Triangles: Time = 12 hours; Diamonds: Time = 24 hours) and pigmentation (Yellow = Light melanocytes; Brown = Dark melanocytes) are highlighted, while in b), it is the time (Squares: Time = 0; Dots: Time = 6 hours; Triangles: Time = 12 hours; Diamonds: Time = 24 hours) and the type of KCM used which are highlighted (Green: KCM-; Red: KCM+).
Most significantly upregulated genes at more than one time point (non-coding RNAs are indicated with *) (Bonferroni-adjusted p-value <0.0001).
| Time points | Gene symbol | Accession number | Description |
|---|---|---|---|
|
|
| NM_004110 | ferredoxin reductase, nuclear gene encoding mitochondrial protein |
|
| NM_004431 | EPH receptor A2 | |
|
| NM_001024662 | ribosomal protein L6 | |
|
| NM_152718 | von Willebrand factor C and EGF domains | |
|
| NM_006398 | ubiquitin D | |
|
| NM_001511 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | |
|
| NM_002392 | Mdm2 p53 binding protein homolog (mouse), transcript variant MDM2 | |
|
| NM_001035267 | ribosomal protein L41 | |
|
| NM_003841 | tumor necrosis factor receptor superfamily, member 10c | |
|
| NM_000107 | damage-specific DNA binding protein 2, 48kDa | |
|
| NM_000839 | glutamate receptor, metabotropic 2 | |
|
| NM_004881 | tumor protein p53 inducible protein 3 | |
|
| NM_014301 | iron-sulfur cluster scaffold homolog (E. coli) | |
|
|
| NM_001924 | growth arrest and DNA-damage-inducible, alpha |
|
| NM_004073 | polo-like kinase 3 | |
|
| NM_006763 | BTG family, member 2 | |
|
| NM_016399 | TP53 regulated inhibitor of apoptosis 1 | |
|
| NM_145886 | p53-induced death domain protein | |
|
| NM_078467 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | |
|
| NM_033285 | tumor protein p53 inducible nuclear protein 1 | |
|
| THC2527965 | Sestrin 1, partial (68%) | |
|
| NM_004323 | BCL2-associated athanogene | |
|
| NM_004628 | xeroderma pigmentosum, complementation group C | |
| *lincRNA chrX:64042150–64093950 | |||
|
|
| NM_002952 | ribosomal protein S2 |
|
| THC2550570 | ribosomal protein L26, partial (91%) | |
|
| NM_012401 | plexin B2 | |
|
| NM_000422 | keratin 17 | |
|
| NM_001613 | actin, alpha 2, smooth muscle, aorta | |
|
| NM_018837 | sulfatase 2 | |
|
| NM_030916 | poliovirus receptor-related 4 | |
|
| NM_001321 | cysteine and glycine-rich protein 2 | |
|
| NM_018370 | DNA-damage regulated autophagy modulator 1 | |
|
| NM_014417 | BCL2 binding component 3 | |
|
| NR_033752 | NmrA-like family domain containing 1 pseudogene, non-coding RNA | |
|
| NM_006509 | v-rel reticuloendotheliosis viral oncogene homolog B | |
|
| AK098072 | cDNA FLJ40753 fis, clone TRACH2001188. | |
|
| NM_020775 | KIAA1324 | |
|
| NM_002514 | nephroblastoma overexpressed gene | |
|
| NM_015920 | ribosomal protein S27-like | |
|
| NM_016335 | proline dehydrogenase (oxidase) 1, nuclear gene encoding mitochondrial protein | |
|
|
| NM_004864 | growth differentiation factor 15 |
|
| NM_020529 | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | |
Most significantly downregulated genes at more than one time point (non-coding RNAs are indicated with *) (Bonferroni-adjusted p-value <0.0001).
| Time points | Gene symbol | Accession number | Description |
|---|---|---|---|
|
|
| NM_002306 | lectin, galactoside-binding, soluble, 3 |
|
| NM_020381 | prenyl (decaprenyl) diphosphate synthase, subunit 2 | |
|
| NM_152900 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | |
|
| NM_015310 | pleckstrin and Sec7 domain containing 3 | |
| *lincRNA chr10:114583921–114587485 forward strand | |||
|
|
| NM_030962 | SET binding factor 2 |
|
| NM_022550 | X-ray repair complementing defective repair in Chinese hamster cells 4 | |
|
| NM_003371 | vav 2 guanine nucleotide exchange factor | |
|
| NM_005012 | receptor tyrosine kinase-like orphan receptor 1 | |
|
| NM_178040 | ELKS/RAB6-interacting/CAST family member 1 | |
| *lincRNA chr17:67547498–67549996 forward strand | |||
|
|
| NM_006339 | high mobility group 20B |
|
| NM_006082 | tubulin, alpha 1b | |
|
| NM_022743 | SET and MYND domain containing 3 | |
|
| NM_152540 | sec1 family domain containing 2 | |
|
| NM_145206 | vesicle transport through interaction with t-SNAREs homolog 1A (yeast) | |
|
| NM_007244 | proline rich 4 (lacrimal) | |
|
| NM_019619 | par-3 partitioning defective 3 homolog (C. elegans) | |
|
| NM_014857 | RAB GTPase activating protein 1-like | |
|
| NM_001145418 | tetratricopeptide repeat domain 28 | |
|
| NM_000282 | propionyl CoA carboxylase, alpha polypeptide | |
|
| NM_020379 | mannosidase, alpha, class 1C, member 1 | |
|
| NM_017436 | alpha 1,4-galactosyltransferase | |
|
| NM_012331 | methionine sulfoxide reductase A | |
|
| NM_178826 | anoctamin 4 | |
|
| NM_012446 | single-stranded DNA binding protein 2 | |
|
| NM_004853 | syntaxin 8 | |
|
| NM_020695 | REX1, RNA exonuclease 1 homolog (S. cerevisiae) | |
|
| NM_031892 | SH3-domain kinase binding protein 1 | |
|
| NM_198428 | Bardet-Biedl syndrome 9 | |
|
| NM_000056 | branched chain keto acid dehydrogenase E1, beta polypeptide | |
|
| NM_001206572 | sortilin-related VPS10 domain containing receptor 1 | |
|
| NM_022445 | thiamin pyrophosphokinase 1 | |
|
| NM_152570 | leucine rich repeat and Ig domain containing 2 | |
|
| NM_023037 | furry homolog (Drosophila) | |
|
| NM_000922 | phosphodiesterase 3B, cGMP-inhibited | |
|
| NM_172109 | potassium voltage-gated channel, KQT-like subfamily, member 2 | |
|
| THC2525667 | Peptidylprolyl isomerase A | |
| *lincRNA chr2:7214634–7218011 reverse strand | |||
| *lincRNA chr4:79892901–80229698 forward strand | |||
| *lincRNA chr18:42263052–42278652 forward strand | |||
| *lincRNA chr18:74178337–74203637 forward strand | |||
| *lincRNA chr7:125564239–125734564 forward strand | |||
|
|
| NM_001017961 | family with sequence similarity 78, member B |
|
| NM_006113 | vav 3 guanine nucleotide exchange factor | |
Top 50 upregulated genes in LM vs DM at 6 hours after UVB irradiation (non-coding RNAs are indicated with *) (Bonferroni-adjusted p-value <0.0001).
| Gene symbol | Accession number | Description |
|---|---|---|
|
| NM_000077 | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) |
|
| NR_024214 | small ILF3/NF90-associated RNA A3, small nuclear RNA |
|
| NM_020802 | uncharacterized protein KIAA1377 |
|
| NM_145170 | tetratricopeptide repeat domain 18 |
|
| NM_001242607 | neural cell adhesion molecule 1, tr. variant 5 |
|
| NM_006361 | homeobox B13 |
|
| NM_013258 | PYD and CARD domain containing |
|
| NM_001172173 | cysteine-serine-rich nuclear protein 3 |
|
| NM_182687 | protein kinase, membrane associated tyrosine/threonine 1 |
| *lincRNA:chr1:85932812–85974062 reverse strand | ||
|
| NM_012413 | glutaminyl-peptide cyclotransferase |
|
| NM_001242310 | ectodysplasin A2 receptor |
|
| NM_147156 | sphingomyelin synthase 1 |
|
| NM_000998 | ribosomal protein L37a |
|
| NM_003546 | histone cluster 1, H4l |
|
| NM_182569 | glycerophosphodiester phosphodiesterase domain containing 1 |
|
| NM_003537 | histone cluster 1, H3b |
| *lincRNA:chr10:133738235–133744210 forward strand | ||
|
| NM_030792 | Glycerophosphodiester phosphodiesterase domain containing 5 |
|
| NM_032701 | suppressor of variegation 4–20 homolog 2 (Drosophila) |
|
| NM_024761 | MOB1, Mps One Binder kinase activator-like 2B (yeast) |
|
| NM_031300 | MAX dimerization protein 3 |
|
| NM_006082 | tubulin, alpha 1b |
|
| NM_013299 | SAC3 domain containing 1 |
| * | NM_001163692 | ubiquitin-associated protein 1-like |
|
| NR_000005 | small nucleolar RNA, C/D box 15A, small nucleolar RNA |
|
| NM_021998 | zinc finger protein 711 |
| *lincRNA:chrX:102139220–102156619 forward strand | ||
|
| ENST00000525443 | latent transforming growth factor beta binding protein 3 |
|
| NM_016010 | family with sequence similarity 164, member A |
|
| ENST00000523711 | Rho guanine nucleotide exchange factor (GEF) 10 |
|
| NM_006272 | S100 calcium binding protein B |
|
| NM_005517 | high mobility group nucleosomal binding domain 2 |
|
| NM_001204088 | C1ORF15-NBL1 readthrough |
|
| NM_024572 | polypeptide N-acetylgalactosaminyltransferase 14 (GalNAc-T14) |
|
| NM_018327 | serine palmitoyltransferase, long chain base subunit 3 |
|
| NM_032036 | interferon, alpha-inducible protein 27-like 2 |
|
| NM_005977 | ring finger protein (C3H2C3 type) 6 |
|
| NM_177987 | tubulin, beta 8 |
|
| NM_006207 | platelet-derived growth factor receptor-like |
|
| ENST00000367534 | actin related protein 2/3 complex, subunit 5, 16kDa |
|
| NM_000954 | prostaglandin D2 synthase 21kDa (brain) |
|
| NM_052885 | solute carrier family 2 (facilitated glucose transporter), member 13 |
|
| NM_003793 | Cathepsin F |
| * | NR_024337 | SERTAD4 antisense RNA 1 |
|
| NM_021197 | WAP four-disulfide core domain 1 |
|
| NM_001070 | tubulin, gamma 1 |
|
| NM_024628 | solute carrier family 12, member 8 |
|
| NM_001338 | coxsackie virus and adenovirus receptor |
|
| NM_152989 | SRY (sex determining region Y)-box 5 |
Top 50 upregulated genes in DM vs LM at 6 hours after UVB irradiation (non-coding RNAs are indicated with *) (Bonferroni-adjusted p-value <0.0001).
| Gene symbol | Accession numer | Description |
|---|---|---|
|
| THC2550570 | ribosomal protein L26 partial (91%) |
|
| NM_002421 | matrix metallopeptidase 1 (interstitial collagenase) |
|
| NM_000972 | ribosomal protein L7a |
|
| NM_002982 | chemokine (C-C motif) ligand 2 |
|
| NM_002523 | neuronal pentraxin II |
|
| NM_058174 | collagen, type VI, alpha 2 |
|
| NM_002961 | S100 calcium binding protein A4 |
|
| NM_001511 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
| NM_000600 | interleukin 6 (interferon, beta 2) |
|
| NM_015444 | transmembrane protein 158 (gene/pseudogene) |
|
| NM_015430 | peptidase domain containing associated with muscle regeneration 1 |
|
| NM_001042590 | collagen, type VI, alpha 2 |
|
| NM_002994 | chemokine (C-X-C motif) ligand 5 |
|
| NM_153046 | tudor domain containing 9 |
|
| NM_139314 | angiopoietin-like 4 |
|
| NM_020182 | prostate transmembrane protein, androgen induced 1 |
|
| NR_003531 | maternally expressed 3 (non-protein coding) non-coding RNA |
|
| ENST00000412019 | C1D nuclear receptor corepressor pseudogene |
|
| NM_001212 | complement component 1, q subcomponent binding protein |
|
| NR_024060 | family with sequence similarity 27, member A, non-coding RNA |
|
| NM_017870 | transmembrane protein 132A |
|
| NM_006517 | solute carrier family 16, member 2 (monocarboxylic acid transporter 8) |
|
| NM_001150 | alanyl (membrane) aminopeptidase |
| *lincRNA:chr2:239460050–239536125 forward strand | ||
|
| NM_054034 | fibronectin 1 |
|
| NM_133337 | myoferlin |
|
| NM_173200 | nuclear receptor subfamily 4, group A, member 3 |
|
| NM_005864 | embryonal Fyn-associated substrate |
|
| NM_024719 | growth hormone regulated TBC protein 1 |
|
| NM_002546 | tumor necrosis factor receptor superfamily, member 11b |
|
| NM_022047 | differentially expressed in FDCP 6 homolog (mouse) |
| * | NR_024060 | family with sequence similarity 27, member A, non-coding RNA |
|
| NM_000963 | prostaglandin-endoperoxide synthase 2 |
|
| NM_002098 | guanylate cyclase activator 1B (retina) |
|
| NM_134470 | interleukin 1 receptor accessory protein |
|
| NM_145006 | sushi domain containing 3 |
| *lincRNA:chr17:73585552–73590170 forward strand | ||
|
| NM_000363 | troponin I type 3 (cardiac) |
|
| NM_006829 | chromosome 10 open reading frame 116 |
|
| NM_012445 | spondin 2, extracellular matrix protein |
|
| NM_144586 | LY6/PLAUR domain containing 1 |
|
| NM_004843 | interleukin 27 receptor, alpha |
|
| NM_000148 | fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group) |
|
| NM_052813 | caspase recruitment domain family, member 9 1 |
|
| NM_016609 | solute carrier family 22, member 17 |
|
| NM_000641 | interleukin 11 |
|
| NM_006291 | tumor necrosis factor, alpha-induced protein 2 |
|
| NM_032413 | chromosome 15 open reading frame 48 |
|
| NM_002526 | 5'-nucleotidase, ecto (CD73) |
|
| NM_002090 | chemokine (C-X-C motif) ligand 3 |
KEGG pathway enrichment analysis of the upregulated and downregulated genes in DM and LM after UVB irradiation.
| DM | LM | |||
|---|---|---|---|---|
| Pathway | Adj-p | Pathway | Adj-p | |
|
| p53 signaling pathway | 9.49E-07 | p53 signaling pathway | 7.04E-07 |
| Ribosome | 3.00E-04 | Ribosome | 2.43E-06 | |
|
| Ribosome | 3.22E-11 | Systemic lupus erythematosus | 1.16E-06 |
| RNA transport | 7.11E-07 | Ribosome | 1.47E-06 | |
| Ribosome biogenesis in eukaryotes | 7.00E-04 | p53 signaling pathway | 1.10E-03 | |
| p53 signaling pathway | 2.13E-02 | Mismatch repair | 5.40E-03 | |
| Pathways in cancer | 6.90E-03 | |||
| Apoptosis | 7.90E-03 | |||
|
| Ribosome | 1.06E-09 | Ribosome | 7.38E-06 |
| p53 signaling pathway | 1.50E-03 | |||
|
| Adherens junction | 1.51E-08 | Ubiquitin mediated proteolysis | 6.84E-12 |
| Ubiquitin mediated proteolysis | 7.21E-08 | Adherens junction | 5.23E-11 | |
| Wnt signaling pathway | 9.12E-06 | Endocytosis | 6.14E-06 | |
| Colorectal cancer | 3.53E-05 | Wnt signaling pathway | 3.14E-05 | |
| Progesterone-mediated oocyte maturation | 4.04E-05 | Progesterone-mediated oocyte maturation | 5.32E-05 | |
| Endocytosis | 6.24E-05 | Cell cycle | 7.36E-05 | |
| Pathways in cancer | 7.60E-05 | Insulin signaling pathway | 5.00E-04 | |
| Systemic lupus erythematosus | 1.00E-04 | Oocyte meiosis | 7.00E-04 | |
| Cell cycle | 9.00E-04 | Pathways in cancer | 7.00E-04 | |
| Oocyte meiosis | 1.00E-03 | Colorectal cancer | 1.20E-03 | |
| Endometrial cancer | 1.10E-03 | Neurotrophin signaling pathway | 2.60E-03 | |
| Fc epsilon RI signaling pathway | 1.70E-03 | Fc gamma R-mediated phagocytosis | 8.60E-03 | |
| B cell receptor signaling pathway | 1.80E-03 | Endometrial cancer | 1.18E-02 | |
| ErbB signaling pathway | 1.90E-03 | Chronic myeloid leukemia | 1.54E-02 | |
| Fc gamma R-mediated phagocytosis | 2.20E-03 | Bacterial invasion of epithelial cells | 1.76E-02 | |
| T cell receptor signaling pathway | 2.50E-03 | Fc epsilon RI signaling pathway | 2.11E-02 | |
| Insulin signaling pathway | 5.30E-03 | Chemokine signaling pathway | 4.22E-02 | |
| Neurotrophin signaling pathway | 1.97E-02 | ErbB signaling pathway | 4.22E-02 | |
| T cell receptor signaling pathway | 4.22E-02 | |||
|
| Metabolic pathways | 4.43E-05 | Protein processing in endoplasmic reticulum | 2.00E-03 |
| Adherens junction | 1.00E-04 | |||
| Fc gamma R-mediated phagocytosis | 3.00E-04 | |||
| Propanoate metabolism | 1.10E-03 | |||
| Protein processing in endoplasmic reticulum | 2.70E-03 | |||
| Systemic lupus erythematosus | 3.10E-03 | |||
| Purine metabolism | 4.90E-03 | |||
| Regulation of actin cytoskeleton | 1.20E-02 | |||
| Valine, leucine and isoleucine degradation | 4.30E-02 | |||
| Pyrimidine metabolism | 4.30E-02 | |||
|
| Cell cycle | 2.20E-08 | ||
| Systemic lupus erythematosus | 8.56E-06 | |||
| - | DNA replication | 2.54E-05 | ||
| Oocyte meiosis | 2.00E-03 | |||
| Lysine degradation | 2.12E-02 |
Fig 3Proposed mechanism for the involvement of ribosomal proteins, MDM2 and p53 signaling pathway in the response to UVB irradiation.
KEGG pathway enrichment analysis for genes upregulated in the culture with KCM+ vs KCM- (significant pathways for the downregulated ones were not observed).
| LM | DM | |||
|---|---|---|---|---|
| Pathway | Adj-p | Pathway | Adj-p | |
|
| Ubiquitin mediated proteolysis | 1.00E-03 | - | |
| mTOR signaling pathway | 4.34E-02 | |||
|
| Neurotrophin signaling pathway | 8.03E-05 | - | |
| Phosphatidylinositol signaling system | 5.50E-03 | |||
| Endocytosis | 2.28E-02 | |||
|
| RNA transport | 1.50E-03 | Focal adhesion | 4.85E-05 |
| Insulin signaling pathway | 4.70E-03 | |||
| Ubiquitin mediated proteolysis | 4.90E-03 | |||
| Homologous recombination | 7.60E-03 | |||
| mRNA surveillance pathway | 8.30E-03 | |||
| SNARE interactions in vesicular transport | 9.50E-03 | |||
| Spliceosome | 1.24E-02 | |||
| Cell cycle | 1.66E-02 | |||
| Pyrimidine metabolism | 1.89E-02 | |||
| Ribosome biogenesis in eukaryotes | 2.23E-02 | |||
| Wnt signaling pathway | 4.46E-02 |
Top 50 upregulated genes in LM vs DM under basal conditions (non- coding RNAs are indicated with *) (bonferroni-adjusted p-value <0.0001).
| Locus name | Accession number | Description |
|---|---|---|
|
| NM_004047 | ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b |
|
| NM_004691 | ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1 |
|
| NM_000150 | fucosyltransferase 6 (alpha (1,3) fucosyltransferase) |
|
| NM_213606 | solute carrier family 16, member 12 |
|
| NM_172002 | HscB iron-sulfur cluster co-chaperone homolog (E. coli) |
|
| NM_001195605 | zinc finger protein 865 |
|
| NM_005864 | embryonal Fyn-associated substrate |
|
| NM_002277 | keratin 31 |
|
| NM_001199973 | RPL36A-HNRNPH2 readthrough |
|
| NM_001145348 | jumonji domain containing 5 |
|
| NM_003542 | histone cluster 1, H4c |
|
| NM_001496 | GDNF family receptor alpha 3 |
|
| NM_032424 | KIAA1826 |
|
| NM_145261 | DnaJ (Hsp40) homolog, subfamily C, member 19 |
|
| NM_177977 | huntingtin-associated protein 1 |
|
| NM_025076 | UDP-glucuronate decarboxylase 1 |
|
| NM_004866 | secretory carrier membrane protein 1 |
|
| NM_000895 | leukotriene A4 hydrolase |
|
| NM_016141 | dynein, cytoplasmic 1, light intermediate chain 1 |
|
| NM_006309 | leucine rich repeat (in FLII) interacting protein 2 |
|
| NM_024942 | chromosome 10 open reading frame 88 |
|
| NM_005018 | programmed cell death 1 |
|
| ENST00000491265 | mitotic spindle organizing protein 2A |
|
| NM_002388 | minichromosome maintenance complex component 3 |
|
| NM_001010868 | chromosome 6 open reading frame 163 |
|
| NM_015177 | deltex homolog 4 (Drosophila) |
|
| NM_021735 | chloride channel 6 (CLCN6) |
|
| NM_018339 | riboflavin kinase |
|
| NM_005663 | Wolf-Hirschhorn syndrome candidate 2 |
|
| NM_001004356 | fibroblast growth factor receptor-like 1 |
|
| NM_033271 | BTB (POZ) domain containing 6 |
|
| NM_153029 | NEDD4 binding protein 1 |
|
| NM_002758 | mitogen-activated protein kinase kinase 6 |
|
| NM_015932 | proteasome maturation protein |
|
| NM_002040 | GA binding protein transcription factor, alpha subunit 60kDa |
|
| NM_023011 | UPF3 regulator of nonsense transcripts homolog A (yeast) |
|
| NM_019091 | pleckstrin homology domain containing, family A member 3 |
|
| NM_001024736 | CD276 molecule (CD276) |
|
| NM_203468 | ectonucleoside triphosphate diphosphohydrolase 2 |
|
| NM_032998 | death effector domain containing |
|
| ENST00000375348 | family with sequence similarity 70, member B |
|
| NM_006739 | minichromosome maintenance complex component 5 |
|
| NR_034022 | zinc finger protein 655 pseudogene |
|
| NR_003002 | small Cajal body-specific RNA 13 |
|
| NM_005871 | survival motor neuron domain containing 1 |
|
| NM_033429 | calmodulin-like 4 |
|
| NM_152379 | chromosome 1 open reading frame 131 |
|
| NM_003800 | RNA guanylyltransferase and 5'-phosphatase |
|
| NM_004519 | potassium voltage-gated channel, KQT-like subfamily, member 3 |
|
| NM_006646 | WAS protein family, member 3 |
Top 50 upregulated genes in DM vs LM under basal conditions (non- coding RNAs are indicated with *) (bonferroni-adjusted p-value <0.0001).
| Locus name | Accession number | Description |
|---|---|---|
|
| NM_002415 | macrophage migration inhibitory factor |
|
| ENST00000395886 | tetratricopeptide repeat domain 19 |
|
| ENST00000361789 | mitochondrially encoded cytochrome b |
|
| NM_015678 | neurobeachin |
|
| NM_001334 | cathepsin O |
|
| NR_002962 | small nucleolar RNA, H/ACA box 23 |
|
| NM_000304 | peripheral myelin protein 22 |
|
| NM_001511 | chemokine ligand (melanoma growth stimulating activity, alpha) |
|
| NM_058197 | cyclin-dependent kinase inhibitor 2A (melanoma, p16) |
|
| NM_001171610 | LIM domain binding 3 |
|
| NM_005932 | mitochondrial intermediate peptidase |
|
| NM_139047 | mitogen-activated protein kinase 8 |
|
| NR_000005 | small nucleolar RNA, C/D box 15A |
|
| NR_024214 | small ILF3/NF90-associated RNA A3 |
|
| NM_015947 | activating signal cointegrator 1 complex subunit 1 |
|
| NM_004234 | zinc finger protein 235 |
|
| NM_001144891 | MAP3K12 binding inhibitory protein 1 |
|
| NM_001198908 | chromosome 13 open reading frame 38 |
|
| NR_024477 | hypothetical LOC100132707 |
|
| NM_007124 | utrophin |
|
| NM_001743 | calmodulin 2 (phosphorylase kinase, delta) |
|
| NM_005943 | molybdenum cofactor synthesis 1 |
|
| NM_012256 | zinc finger protein 212 |
|
| NM_015047 | KIAA0090 (KIAA0090) |
|
| NR_003271 | small nucleolar RNA, C/D box 3B-1 |
|
| NM_021958 | H2.0-like homeobox |
|
| NM_145005 | chromosome 9 open reading frame 72 |
|
| NM_032985 | Sec23 homolog B (S. cerevisiae) |
|
| NM_017818 | WD repeat containing, antisense to TP73 |
|
| NM_005907 | mannosidase, alpha, class 1A, member 1 |
|
| NM_006272 | S100 calcium binding protein B |
|
| NM_019044 | coiled-coil domain containing 93 |
|
| NM_032924 | zinc finger protein 3 |
|
| NM_002032 | ferritin, heavy polypeptide 1 |
|
| NM_014488 | RAB30, member RAS oncogene family |
|
| NM_001034836 | RAD52 motif 1 |
|
| NM_003972 | BTAF1 RNA polymerase II, |
|
| NM_018950 | major histocompatibility complex, class I, F |
|
| NM_012189 | calcium binding tyrosine-(Y)-phosphorylation regulated |
|
| NM_004579 | mitogen-activated protein kinase 2 |
|
| ENST00000320054 | PRP18 pre-mRNA processing factor 18 homolog (S. cerevisiae) |
|
| NM_005184 | calmodulin 3 (phosphorylase kinase, delta) |
|
| NM_017621 | alkB, alkylation repair homolog 4 (E. coli) |
|
| NR_024497 | hypothetical LOC399744 |
|
| NM_024860 | SET domain containing 6 |
|
| NM_024577 | SH3 domain and tetratricopeptide repeats 2 |
|
| NM_004491 | Rho GTPase activating protein 35 |
|
| NM_032343 | coiled-coil-helix-coiled-coil-helix domain containing 6 |
|
| NM_018835 | ring finger and CCCH-type domains 2 |
|
| NM_005452 | WD repeat domain 46 |
Fig 4Gene expression of genes FDX6, RPL6, MDM2, TP53I3, ATP6VOB and MIF assessed by RT-qPCR.
Unpaired t-test; *** p<0.0001; ** p<0.001; * p<0.01.